Full results from two Lilly trials of the novel triple hormone receptor agonist show reductions in A1c, osteoarthritis knee pain, and obstructive sleep apnea.

Patients with obesity and type 2 diabetes have more favorable QOL outcomes taking a GLP-1 than those with either condition alone or with multiple comorbidities.

More nurses regularly take on second shifts but as the practice becomes normalized, is this best for patients?

A 14-month-old female with a history of atopy presented with an 8-month history of a persistent, non-tender, non-bleeding ...

New research suggests that time and aging change how people deal with regrets. Here’s what it could mean for doctors.

Patients with RA have a higher risk of blood clots and serious infections with baricitinib vs older biologics, but not heart disease or cancer, according to two safety trials.

Weekly subcutaneous injections of the novel B-cell inhibitor obexelimab significantly reduces disease flares and lowers toxic ...

For men with localized prostate cancer, proton therapy looks no better than IMRT when it comes to 3-year biochemical ...

Learning through art history that obesity once denoted prosperity, strength, and beauty, may help healthcare providers treat ...

A pilot study shows that a urine-based metabolite panel accurately distinguishes children with autism from typically ...

Phase 3 data on sunvozertinib for EGFR exon 20 insertions and sacituzumab tirumotecan plus pembrolizumab for PD-L1-positive ...

Disease activity, organ involvement, and treatment choice all shape infection risk in lupus and rheumatoid arthritis, with ...